Global Aortic Aneurysm Market

Aortic Aneurysm Comprehensive Study by Type (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA)), Application (Ambulatory Surgical Centers, Hospital), Treatment (Endovascular Aneurysm Repair, Open Surgical Repair), Product (Stent Graft, Catheter)

Aortic Aneurysm Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Aortic Aneurysm Market Scope
An aortic aneurysm is an abnormal bulge that occurs in the wall of the major blood vessel (aorta) that carries blood from the heart to the body. Aortic aneurysms can occur anywhere in the aorta and may be tube-shaped (fusiform) or round (saccular). An aortic dissection occurs when a tear develops in the inner layer of the wall of the aorta. This causes one or more of the layers of the wall of the aorta to separate, which weakens the wall of the aorta. Having an aortic aneurysm also increases your risk that the aneurysm can burst (rupture). Aortic Aneurysm is expected to increase in forthcoming years, due to the increase in the geriatric population and the rise in tobacco consumption.



In this market, companies are completely focused on research and development to develop drugs or devices. The companies are exploring the market in new regions by expansions, investments, collaboration, and partnership as their preferred strategies Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Aortic Aneurysm market throughout the predicted period.

Medtronic Plc (Ireland), Cook Medical (United States), Terumo Medical Corporation (United States), Microport Scientific Corporation (China), Getinge (Sweden), Endologix, Inc. (United States), W. L. Gore & Associates (United States), Lombard Medical Limited (United Kingdom), CryoLife, Inc. (United States) and Cardinal Health, Inc (United States) are some of the key players that are part of study coverage.

Segmentation Overview
The study have segmented the market of Global Aortic Aneurysm market by Type (Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA)), by Application (Ambulatory Surgical Centers and Hospital) and Region with country level break-up.

On the basis of geography, the market of Aortic Aneurysm has been segmented into .

Influencing Trend:
Introduction of New Diagnosis Tools

Market Growth Drivers:
High Prevalence of Tobacco Smoking in the Developed and Developing Region and Rise in the Geriatric Population with Cardiovascular Diseases

Challenges:
Less Treatment Options Available for Thoracic Aortic Aneurysm Repair and Biochemical Issues in the Endovascular Device Design

Restraints:
High Treatment Cost and Cost of Device

Opportunities:
Reimbursement Scenarios for the Surgical Treatment of Aortic Aneurysms and Continuous Advancements, in terms of Technology, in Endovascular Surgical Procedures

Market Leaders and their Expansionary Development Strategies
In April 2018, Vascutek Ltd and Bolton Medical, Inc. have merged to produce one single business unit. It is expected that following this acquisition, the merged company is likely to reinforce its position in the global market and expand its portfolio of medical products.
In May 2020, Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the TREO™ Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Aortic Aneurysm Manufacturers, Suppliers, and Dealers, Medical Devices Companies, Raw Material Suppliers, Market Research and Consulting Service Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and Hospitals and Healthcare Institutions

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
By Application
  • Ambulatory Surgical Centers
  • Hospital
By Treatment
  • Endovascular Aneurysm Repair
  • Open Surgical Repair

By Product
  • Stent Graft
  • Catheter

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. High Prevalence of Tobacco Smoking in the Developed and Developing Region
        • 3.2.2. Rise in the Geriatric Population with Cardiovascular Diseases
      • 3.3. Market Challenges
        • 3.3.1. Less Treatment Options Available for Thoracic Aortic Aneurysm Repair
        • 3.3.2. Biochemical Issues in the Endovascular Device Design
      • 3.4. Market Trends
        • 3.4.1. Introduction of New Diagnosis Tools
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Aortic Aneurysm, by Type, Application, Treatment and Product (value) (2017-2022)
      • 5.1. Introduction
      • 5.2. Global Aortic Aneurysm (Value)
        • 5.2.1. Global Aortic Aneurysm by: Type (Value)
          • 5.2.1.1. Abdominal Aortic Aneurysm (AAA)
          • 5.2.1.2. Thoracic Aortic Aneurysm (TAA)
        • 5.2.2. Global Aortic Aneurysm by: Application (Value)
          • 5.2.2.1. Ambulatory Surgical Centers
          • 5.2.2.2. Hospital
        • 5.2.3. Global Aortic Aneurysm by: Treatment (Value)
          • 5.2.3.1. Endovascular Aneurysm Repair
          • 5.2.3.2. Open Surgical Repair
        • 5.2.4. Global Aortic Aneurysm by: Product (Value)
          • 5.2.4.1. Stent Graft
          • 5.2.4.2. Catheter
    • 6. Aortic Aneurysm: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2022)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. Medtronic Plc (Ireland)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. Cook Medical (United States)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. Terumo Medical Corporation (United States)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. Microport Scientific Corporation (China)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. Getinge (Sweden)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. Endologix, Inc. (United States)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. W. L. Gore & Associates (United States)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Lombard Medical Limited (United Kingdom)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. CryoLife, Inc. (United States)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
        • 6.4.10. Cardinal Health, Inc (United States)
          • 6.4.10.1. Business Overview
          • 6.4.10.2. Products/Services Offerings
          • 6.4.10.3. Financial Analysis
          • 6.4.10.4. SWOT Analysis
    • 7. Global Aortic Aneurysm Sale, by Type, Application, Treatment and Product (value) (2023-2028)
      • 7.1. Introduction
      • 7.2. Global Aortic Aneurysm (Value)
        • 7.2.1. Global Aortic Aneurysm by: Type (Value)
          • 7.2.1.1. Abdominal Aortic Aneurysm (AAA)
          • 7.2.1.2. Thoracic Aortic Aneurysm (TAA)
        • 7.2.2. Global Aortic Aneurysm by: Application (Value)
          • 7.2.2.1. Ambulatory Surgical Centers
          • 7.2.2.2. Hospital
        • 7.2.3. Global Aortic Aneurysm by: Treatment (Value)
          • 7.2.3.1. Endovascular Aneurysm Repair
          • 7.2.3.2. Open Surgical Repair
        • 7.2.4. Global Aortic Aneurysm by: Product (Value)
          • 7.2.4.1. Stent Graft
          • 7.2.4.2. Catheter
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Aortic Aneurysm: by Type(USD Million)
    • Table 2. Aortic Aneurysm: by Application(USD Million)
    • Table 3. Aortic Aneurysm: by Treatment(USD Million)
    • Table 4. Aortic Aneurysm: by Product(USD Million)
    • Table 5. Company Basic Information, Sales Area and Its Competitors
    • Table 6. Company Basic Information, Sales Area and Its Competitors
    • Table 7. Company Basic Information, Sales Area and Its Competitors
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Company Basic Information, Sales Area and Its Competitors
    • Table 14. Company Basic Information, Sales Area and Its Competitors
    • Table 15. Aortic Aneurysm: by Type(USD Million)
    • Table 16. Aortic Aneurysm: by Application(USD Million)
    • Table 17. Aortic Aneurysm: by Treatment(USD Million)
    • Table 18. Aortic Aneurysm: by Product(USD Million)
    • Table 19. Research Programs/Design for This Report
    • Table 20. Key Data Information from Secondary Sources
    • Table 21. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Aortic Aneurysm: by Type USD Million (2017-2022)
    • Figure 5. Global Aortic Aneurysm: by Application USD Million (2017-2022)
    • Figure 6. Global Aortic Aneurysm: by Treatment USD Million (2017-2022)
    • Figure 7. Global Aortic Aneurysm: by Product USD Million (2017-2022)
    • Figure 8. Global Aortic Aneurysm share by Players 2022 (%)
    • Figure 9. Global Aortic Aneurysm share by Players (Top 3) 2022(%)
    • Figure 10. Global Aortic Aneurysm share by Players (Top 5) 2022(%)
    • Figure 11. BCG Matrix for key Companies
    • Figure 12. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
    • Figure 13. Medtronic Plc (Ireland) Revenue: by Geography 2022
    • Figure 14. Cook Medical (United States) Revenue, Net Income and Gross profit
    • Figure 15. Cook Medical (United States) Revenue: by Geography 2022
    • Figure 16. Terumo Medical Corporation (United States) Revenue, Net Income and Gross profit
    • Figure 17. Terumo Medical Corporation (United States) Revenue: by Geography 2022
    • Figure 18. Microport Scientific Corporation (China) Revenue, Net Income and Gross profit
    • Figure 19. Microport Scientific Corporation (China) Revenue: by Geography 2022
    • Figure 20. Getinge (Sweden) Revenue, Net Income and Gross profit
    • Figure 21. Getinge (Sweden) Revenue: by Geography 2022
    • Figure 22. Endologix, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 23. Endologix, Inc. (United States) Revenue: by Geography 2022
    • Figure 24. W. L. Gore & Associates (United States) Revenue, Net Income and Gross profit
    • Figure 25. W. L. Gore & Associates (United States) Revenue: by Geography 2022
    • Figure 26. Lombard Medical Limited (United Kingdom) Revenue, Net Income and Gross profit
    • Figure 27. Lombard Medical Limited (United Kingdom) Revenue: by Geography 2022
    • Figure 28. CryoLife, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 29. CryoLife, Inc. (United States) Revenue: by Geography 2022
    • Figure 30. Cardinal Health, Inc (United States) Revenue, Net Income and Gross profit
    • Figure 31. Cardinal Health, Inc (United States) Revenue: by Geography 2022
    • Figure 32. Global Aortic Aneurysm: by Type USD Million (2023-2028)
    • Figure 33. Global Aortic Aneurysm: by Application USD Million (2023-2028)
    • Figure 34. Global Aortic Aneurysm: by Treatment USD Million (2023-2028)
    • Figure 35. Global Aortic Aneurysm: by Product USD Million (2023-2028)
    List of companies from research coverage that are profiled in the study
    • Medtronic Plc (Ireland)
    • Cook Medical (United States)
    • Terumo Medical Corporation (United States)
    • Microport Scientific Corporation (China)
    • Getinge (Sweden)
    • Endologix, Inc. (United States)
    • W. L. Gore & Associates (United States)
    • Lombard Medical Limited (United Kingdom)
    • CryoLife, Inc. (United States)
    • Cardinal Health, Inc (United States)
    Select User Access Type

    Key Highlights of Report


    May 2023 204 Pages 81 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

    Request Sample Pages

    Budget constraints? Get in touch with us for special pricing


    Check Discount Now
    Global Aortic Aneurysm Market Quantitative research analysis
    Global Aortic Aneurysm Market Qualitative Industry Analysis
    DOWNLOAD SAMPLE PDF

    Talk to Our Experts

    Want to Customize Study?


    "We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

    Make an Enquiry Now

    Frequently Asked Questions (FAQ):

    The Aortic Aneurysm study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
    The Aortic Aneurysm Market is gaining popularity and expected to see strong valuation by 2028 .
    According to AMA, the Global Aortic Aneurysm market is expected to see growth rate of xx%.
    The Aortic Aneurysm market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

    Know More About Global Aortic Aneurysm Market Report?

    Have a Query? Click Here

    Other Related Reports

    Retinitis Pigmentosa Comprehensive Study by Treatment (Acetazolamide Medication, Vitamin A palmitate, Retinal implant, Sunglasses), End-users (Hospitals, Clinics, Others), Diagnosis (Genetic Testing,...
    $ 3750
    Skin Neoplasms Comprehensive Study by Type (Benign Neoplasms, Malignant Neoplasms), Treatment (Chemotherapy, Surgery, Non-Invasive Treatments, Others), End User (Hospital and Clinics, Diagnostic Cent...
    $ 3750
    Transient Ischemic Attack Comprehensive Study by End Users (Hospitals & Clinics, Diagnostic Centers, Research Laboratories), Age Group (0–18 years, 19–40 years, 41–60 years, 60+ years), Diagnosis Typ...
    $ 3750
    Limb Girdle Muscular Dystrophy Comprehensive Study by Type (LGMD1, LGMD2), Application (Hospitals, Clinics, Others), Treatment Type (Occupational Therapy, Respiratory Therapy, Speech Therapy), Diagno...
    $ 3350
    Hypereosinophilic Syndrome Comprehensive Study by Treatment (Corticosteroids, Biological Therapy, Chemotherapy, Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centres), Distribution Chan...
    $ 3750
    Niemann-Pick Disease Comprehensive Study by Type (Niemann-Pick Type A, Niemann-Pick Type B, Niemann-Pick Type C), Application (Genetic Testing and Diagnosis, Therapeutic Research), Treatment (Bone Ma...
    $ 3650